纳布啡与羟考酮自控镇痛对非小细胞肺癌患者术后免疫因子水平影响的比较

doi:10.11904/j.issn.1002-3070.2018.04.005

摘要/Abstract

摘要： 目的比较纳布啡与羟考酮自控静脉镇痛(Patient controlled intravenous analgesia,PCIA)对非小细胞肺癌患者术后免疫因子水平的影响。方法选择我院择期行胸腔镜肺叶切除术的非小细胞肺癌患者80例,分为纳布啡组(N组)和羟考酮组(O组)。术后给予PCIA镇痛,配置方法:N组为1 mg/kg纳布啡+10 mg托烷司琼,O组为羟考酮20 mg+10 mg托烷司琼,均用生理盐水稀释至150 mL。分别在术前30 min(T₀)、术后4 h(T₁)、8 h(T₂)、12 h(T₃)、24 h(T₄)时抽取外周静脉血5 mL,用于测定血清IgG、IgM、IgA、TGF-β1、VEGF及IL-17水平,并计数CD4⁺、CD8⁺T细胞、NK细胞及CD4⁺/CD8⁺比值;分别在T₁、T₂、T₃、T₄时对所有患者进行VAS评分。结果两组患者术后各时间点VAS评分、PCIA泵有效按压次数及总消耗量均无统计学差异(P＞0.05);与O组比较,N组血清IgG水平在T₁~T₄,IgM、IgA水平则在T₂~T₄时要明显更高,而TGF-β1及VEGF水平在T₂~T₄,IL-17水平在T₁~T₄时要更低,CD4⁺T、NK细胞及CD4⁺/CD8⁺比值在T₂~T₄要更高,而CD8⁺T细胞则在T₁~T₄时要更高,差异均有统计学意义(P＜0.05)。结论纳布啡用于非小细胞肺癌患者行胸腔镜肺叶切除术后PCIA能够有效控制术后疼痛,能够增加机体免疫球蛋白及免疫细胞水平,降低肿瘤免疫抑制因子水平,减轻围术期免疫抑制程度,改善机体免疫功能。

关键词: 纳布啡, 羟考酮, 非小细胞肺癌, 胸腔镜肺叶切除术, 免疫因子

Abstract: Objective The aim of this study was to compare the effects of morphine and oxycodone controlled intravenous analgesia(PCIA)on postoperative immunological factor levels in patients with non-small cell lung cancer(NSCLC). Methods Eighty patients with NSCLC who underwent video-assisted thoracic surgical(VATS)lobectomy were enrolled in the study.They were randomly divided into nalbuphine(N group)and oxycodone group(O group).All patients were given PCIA analgesia after operation.Patients in the N group received nalbuphine hydrochloride at dose of 1.0 mg/kg plus 10 mg of tropisetron for PCIA,while patients in the O group received oxycodone hydrochloride 20 mg plus 10 mg of tropisetron,all diluted to 150 mL with physiological saline.Five mL of peripheral venous blood was drawn at 30 min(T₀)before surgery and after surgery for 4(T₁),8(T₂),12(T₃)and 24 h(T₄)to determine serum levels of IgG,IgM,IgA,TGF-β1,VEGF and IL-17,count the cell number of CD4⁺T,CD8⁺T and NK and calculate the ratio of CD4⁺/CD8⁺.VAS scores were performed on all patients at T₁,T₂,T₃ and T₄. Results There were no significant differences in the VAS scores,PCIA pump effective compressions and total consumption of PCIA between the N and O groups(P＞0.05).Compared to the O group,the serum level of IgG at T₁~T₄,IgM and IgA serum levels at T₂~T₄ were high in the N group;serum levels of TGF-β1 and VEGF at T₂~T₄ and IL-17 serum level at T₁~T₄ were low in the N group;the number of CD4⁺T and NK cells,the ratio of CD4⁺/CD8⁺ at T₂~T₄ and the number of CD8⁺ T at T₁~T₄ were high in the N group.The differences were statistically significant(P＜0.05). Conclusion Nalbuphine for patients with NSCLC applied for PCIA after VATS lobectomy can effectively control postoperative pain,significantly increase levels of immunoglobulin and immune cells,reduce the level of tumor immunosuppressive factors,reduce perioperative immunosuppression degree,and improve the body's immune function.

Key words: Nalbuphine, Oxycodone, Non-small cell lung cancer, Video-assisted thoracic surgical lobectomy, Immunological factors

中图分类号:

R734.2

崔晓燕, 涂青, 甘建辉. 纳布啡与羟考酮自控镇痛对非小细胞肺癌患者术后免疫因子水平影响的比较[J]. 实用肿瘤学杂志, 2018, 32(4): 309-314.

CUI Xiaoyan,TU Qing,GAN Jianhui. Comparison between nalbuphine and oxycodone applied for patient controlled analgesia on postoperative immunological factor levels in patients with non-small cell lung cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 309-314.

参考文献

1 Esposito L,Conti D,Ailavajhala R,et al.Lung cancer:Are we up to the challenge?[J].Curr Genomics,2010,11(7):513-518.
2 Desai H,Natt B,Kim S,et al.Anesthesia and fast-track in video-assisted thoracic surgery(VATS):from evidence to practice[J].Ann Am Thorac Soc,2017,14(2):262-266.
3 Paul S,Saroyan A,Chiu YL,et al.Outcomes after lobectomy using thoracoscopy vs. thoracotomy:a comparative effectiveness analysis utilizing the nationwide inpatient sample database[J].Eur J Cardiothorac Surg,2013,43(4):813-817.
4 Paul S,Altorki NK,Sheng S,et al.Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy:a propensity-matched analysis from the STS database[J].J Thorac Cardiovasc Surg,2010,139(2):366-378.
5 McKenna RJ Jr,Houck W,Fuller CB.Video-assisted thoracic surgery lobectomy:experience with 1,100 cases[J].Ann Thorac Surg,2006,81(2):421-426.
6 王庆辉,孙悦,姜万维.探讨氟比洛芬酯应用于宫颈癌手术术后镇痛的临床效果[J].实用肿瘤学杂志,2018,32(1):33-37.
7 林颖,卢建华,陈霞.宫颈癌切除术患者术后羟考酮静脉自控镇痛效果及免疫功能观察[J].山东医药,2017,57(19):60-62.
8 廖美娟,郑雪琴,冯舒韵,等.羟考酮与吗啡术后镇痛对结肠癌根治术患者血小板活性和细胞免疫功能的影响[J].临床麻醉学杂志,2017,33(6):542-545.
9 段凤梅,孙旭颖,许乃欣,等.纳布啡超前镇痛对老年开胸手术患者围术期炎性细胞因子的影响[J].实用医学杂志,2016,32(14):2259-2261.
10 郑威,黄杰.胸腔镜肺叶切除术对非小细胞肺癌患者炎性因子及免疫功能的影响[J].实用癌症杂志,2017,32(2):295-298.
11 Shakhar G1,Ben-Eliyahu S.Potential prophylactic measures against postoperative immunosuppression:could they reduce recurrence rates in oncological patients?[J].Ann Surg Oncol,2003,10(8):972-992.
12 Inada T,Yamanouchi Y,Jomura S,et al.Effect of propofol and isoflurane anaesthesia on the immune response to surgery[J].Anaesthesia,2004,59(10):954-959.
13 Melamed R,Bar-Yosef S,Shakhar G,et al.Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine,thiopental,and halothane,but not by propofol:mediating mechanisms and prophylactic measures[J].Anesth Analg,2003,97(5):1331-1339.
14 Griffis CA,Page G,Kremer M,et al.Implications of immune function to anesthesia care[J].AANA J,2008,76(6):449-454.
15 许幸,吴新民,薛张纲,等.盐酸羟考酮注射液用于全麻患者术后镇痛的有效性和安全性:前瞻性、随机、盲法、多中心、阳性对照临床研究[J].中华麻醉学杂志,2013,33(3):269-274.
16 Zeng Z,Lu J,Shu C,et al.A Comparision of nalbuphine with morphine foranalgesic effects and safety:Meta-analysis of randomized controlled trials[J].Sci Rep,2015,5:10927.
17 熊佳时,何刚,李士英,等.非小细胞肺癌患者外周血T细胞亚群、NK细胞与临床分期及预后的相关性[J].临床肺科杂志,2015,20(7):1183-1186.
18 叶飒,王飞燕,周宏斌,等.非小细胞肺癌患者血清IL-17、VEGF水平与临床分期和预后的相关性研究[J].浙江医学,2018,40(6):573-576.
19 Panchabhai S,Kelemen K,Ahmann G,et al.Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma[J].Leukemia,2016,30(4):951-954.
20 Kondo E,Koda K,Takiguchi NE,et al.Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer[J].Dig Surg,2003,20(5):445-451.
21 Cantarella RA,de Oliveira JK,Dorbandt DM,et al.Effects of topical flurbiprofen sodium,diclofenac sodium,ketorolac tromethamine and benzalkonium chloride on corneal sensitivity in normal dogs[J].Open Vet J,2017,7(3):254-260.
22 Zhang Y,Jiang Q,Li T.Nalbuphine analgesic and anti-inflammatory effects on patients undergoing thoracoscopic lobectomy during the perioperative period[J].Exp Ther Med,2017,14(4):3117-3121.

[1]	孙立春,李丹丹,李净,于凤玲. CCDC8和TGF-β1在非小细胞肺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(3): 215-221.
[2]	李万祯, 殷俊, 李萍, 林晓辉, 张国前, 张书旭. iR-17在非小细胞肺癌放射抗拒细胞中的表达及作用研究[J]. 实用肿瘤学杂志, 2018, 32(5): 391-397.
[3]	蔡静, 候玥. 非小细胞肺癌患者血清miR-195的表达及其临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 415-419.
[4]	雷俊华, 许冠华, 曾江正, 黄芬, 何志惠, 卢彦达. 隐丹参酮联合顺铂抗非小细胞肺癌NCI-H1975细胞JAK2/STAT3机制研究[J]. 实用肿瘤学杂志, 2018, 32(3): 198-202.
[5]	翟可可, 高媛媛, 冯晓, 许静文, 宫玉芳, 孟庆威. 术后辅助化疗后复发转移与初次诊断的IV期NSCLC一线化疗疗效分析[J]. 实用肿瘤学杂志, 2018, 32(2): 107-111.
[6]	杜夜生, 胡松柳, 徐向英. 非小细胞肺癌寡转移的立体定向放射治疗研究[J]. 实用肿瘤学杂志, 2018, 32(2): 154-158.
[7]	王庆辉, 孙悦, 姜万维. 探讨氟比洛芬酯应用于宫颈癌手术术后镇痛的临床效果[J]. 实用肿瘤学杂志, 2018, 32(1): 33-37.
[8]	孙明亮, 徐建宇, 徐向英. 早期非小细胞肺癌立体定向放疗的相关研究[J]. 实用肿瘤学杂志, 2018, 32(1): 53-56.
[9]	代欣综述, 张大昕审校. 非小细胞肺癌抗血管生成治疗研究现状[J]. 实用肿瘤学杂志, 2017, 31(5): 472-476.
[10]	胡海峰, 冯谢敏, 乔健, 段伟, 刘宁宁, 孙晓东. miR-345在非小细胞肺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2017, 31(2): 117-122.
[11]	张锐，王智煜，王帅，赵晖. 重组人血管内皮抑素联合NP方案治疗初诊晚期非小细胞肺癌骨转移疗效及对血清VEGF表达的影响[J]. 实用肿瘤学杂志, 2016, 30(6): 527-522.
[12]	任凤海,王丹丹,王俊峰,徐海,徐世东. 单孔与单操作孔电视辅助胸腔镜手术治疗ⅠA期非小细胞肺癌的临床对比研究[J]. 实用肿瘤学杂志, 2016, 30(4): 327-331.
[13]	叶磊光, 闫安, 刘宝刚. Aurora-A参与非小细胞肺癌化疗药耐药与患者预后的关系[J]. 实用肿瘤学杂志, 2016, 30(2): 97-102.
[14]	陈明慧, 陈喜杰综述, 王艳审校. CD44v6与非小细胞肺癌的研究进展[J]. 实用肿瘤学杂志, 2016, 30(2): 172-175.
[15]	成龙, 周建国, 周航. 培美曲塞维持治疗晚期非小细胞肺癌临床疗效的Meta分析[J]. 实用肿瘤学杂志, 2016, 30(1): 28-35.